GFO Issue 56, Article Number: 1
Sub-title :
Analysis
Author:
Bernard Rivers
Date:
2006-04-17
ABSTRACT
ABSTRACT
Only 23% of the Global Fund grants that have reached the end of their second year have met or exceeded the performance targets that were set by the applicants when they submitted their original proposals to the Fund. A further 56% of grants were deemed by the Fund to have performance that did not meet expectations, but was adequate; 20% were deemed to have performance that was inadequate, but potential had been demonstrated; and 2% had performance that was unacceptable.
Only 23% of the Global Fund grants that have reached the end of their second year have met or exceeded the performance targets that were set by the applicants when they submitted their original proposals to the Fund. These grants were rated "A" by the Fund's Secretariat. A further 56% of grants were rated B1 ("Grant performance has not met expectations, but has been adequate"), 20% were rated B2 ("Grant performance has been inadequate, but potential has been demonstrated"), and 2% were rated C ("Grant performance has been unacceptable").
From its very start, the Global Fund has been guided by two principles that at times conflict with each other. The first of these principles is that each grant is "country-led" - meaning that it's for the recipient country to decide how to run the grant. The second principle is that each grant is "results-based" - meaning that if the grant doesn't deliver the promised results, the Fund has the right to terminate the grant part-way through.
The conflict between these two objectives arises when the Global Fund Secretariat sees that a grant is in trouble. At such a time, should the Fund intervene with suggestions (or, indeed, instructions) regarding what should be done about that grant, or should it remain silent?
Thus far, the Fund has taken a generally hands-off approach in such situations - except when the grant is approaching the end of its second year, at which point the Fund briefly gets much more involved. This is because this is when the Fund has to decide whether the grant should receive the funding to enable it to move from Phase 1 (i.e. Years 1-2) to Phase 2 (Years 3-5).
To help the Board decide whether to approve Phase 2 funding for a particular grant, the Secretariat performs a thorough evaluation of the grant. In the course of this, it compiles a detailed and fairly candid "Grant Scorecard" which is confidential until the Secretariat and the Board have agreed on whether to approve Phase 2, but then is made publicly available at the Fund's website.
Each Grant Scorecard assesses many aspects of the grant's performance, and then combines these assessments into an "Overall Grant Rating", which can have the following values:
A: Grant performance has met or exceeded expectations
B1: Grant performance has not met expectations, but has been adequate
B2: Grant performance has been inadequate, but potential has been demonstrated
C: Grant performance has been unacceptable
Separately, the Secretariat assesses "Contextual Considerations," which relate to factors beyond the control of those involved in grant implementation but that can have an impact on the chances of success.
Finally, after taking into account the "Overall Grant Rating" and the "Contextual Considerations," the Secretariat makes one of the following recommendations:
"Go": The grant should be approved for Phase 2 (i.e. Years 3-5)
"Conditional Go": The grant should be approved for Phase 2, on condition that specified actions are taken by the PR and/or CCM within a specified time period.
"Revised Go": The grant should be approved for Phase 2, subject to specified major changes being made from the original proposal.
"No Go": The grant should not be approved for Phase 2, and should therefore be terminated.
Usually the Board agrees with the Secretarit's recommendation, but occasionally it disagrees. When that happens, the Board and Secretariat re-examine the situation and attempt again to reach agreement. If that is not possible, the final decision is made by the Board after obtaining some input from the Technical Review Panel (TRP).
With the 124 grants for which the Board has thus far made a Phase 2 decision, the Secretarit's ratings were as follows:
Rating
Number of grants
Percent
A
28
23%
B1
69
56%
B2
25
20%
C
2
2%
Total
124
100%
The final Board decisions were as follows:
Board decision
Number of grants
Percent
Go
63
51%
Conditional Go
59
48%
Revised Go
0
0%
No Go
2
2%
Total
124
100%
For each of the 124 grants, the Fund provides at www.theglobalfund.org/en/funds_raised/gsc the above-mentioned Grant Scorecards. These contain not just the Grant Rating, but also some fairly candid comments about the grant. These range from the positive (e.g. "The PR has managed the program efficiently, with the CCM playing an important oversight role. The program has collaborated with partners and responded to problems particularly well, improving its ability to disburse to sub-recipients and in procurement after initial capacity difficulties.") to the fairly negative (e.g. "The Program had a slow start, with sluggish capacity building efforts and procurement delays... The overall management of the Program by the PR has been inadequate. The PR did not disburse funds to sub-recipients on a timely basis or in an effective manner. Late disbursements were largely due to the PR's weak monitoring of reports submitted by the sub-recipients.")
The Grant Ratings and the Board decisions for the 124 grants were as follows:
The 124 grants for which Phase 2 decisions have been made
Country
Round
Disease Component
Grant number
Grant Rating
Board decision re Phase 2
Argentina
1
HIV/AIDS
ARG-102-G01-H
A
Conditional Go
Armenia
2
HIV/AIDS
ARM-202-G01-H
A
Go
Bangladesh
2
HIV/AIDS
BAN-202-G01-H
A
Go
Benin
1
Malaria
BEN-102-G01-M
B1
Conditional Go
Benin
2
TB
BEN-202-G02-T
B1
Go
Benin
2
HIV/AIDS
BEN-202-G03-H
B1
Go
Bulgaria
2
HIV/AIDS
BUL-202-G01-H
A
Go
Burkina Faso
2
HIV/AIDS
BUR-202-G02-H
A
Go
Burundi
2
Malaria
BRN-202-G02-M
B1
Conditional Go
Burundi
1
HIV/AIDS
BRN-102-G01-H
B1
Go
Chad
2
TB
TCD-202-G01-T
B1
Conditional Go
Chile
1
HIV/AIDS
CHL-102-G01-H
B1
Go
Cambodia
1
HIV/AIDS
CAM-102-G01-H
B1
Conditional Go
Cambodia
2
HIV/AIDS
CAM-202-G02-H
B1
Conditional Go
Cambodia
2
Malaria
CAM-202-G03-M
B1
Go
Cambodia
2
TB
CAM-202-G04-T
B1
Conditional Go
Central African Republic
2
HIV/AIDS
CAF-202-G01-H
B1
Go
China
1
TB
CHN-102-G01-T
A
Go
China
1
Malaria
CHN-102-G02-M
A
Go
Columbia
2
HIV/AIDS
COL-202-G01-H
B1
Conditional Go
Costa Rica
2
HIV/AIDS
COR-202-G01-H
B2
Conditional Go
Cote d'Ivoire
3
TB
CIV-304-G03-T
A
Go
Cote d'Ivoire
2
HIV/AIDS
CIV-202-G01-H
B1
Conditional Go
Croatia
2
HIV/AIDS
HRV-202-G01-H
B1
Go
Cuba
1
HIV/AIDS
CUB-202-G01-H
A
Conditional Go
Democratic Rep. of Congo
2
TB
ZAR-202-G01-T
B1
Conditional Go
El Salvador
2
HIV/AIDS
SLV-202-G01-H
B1
Conditional Go
El Salvador
2
TB
SLV-202-G02-T
A
Go
Estonia
2
HIV/AIDS
EST-202-G01-H
B1
Go
Eritrea
2
Malaria
ERT-202-G01-M
B1
Conditional Go
Ethiopia
2
HIV/AIDS
ETH-202-G03-H
B1
Conditional Go
Ethiopia
2
Malaria
ETH-202-G02-M
B2
Conditional Go
Ethiopia
1
TB
ETH-102-G01-T
B2
Conditional Go
Georgia
3
Malaria
GEO-304-G02-M
B1
Go
Georgia
2
HIV/AIDS
GEO-202-G01-H
B1
Go
Ghana
1
HIV/AIDS
GHN-102-G01-H
B1
Conditional Go
Ghana
1
TB
GHN-102-G02-T
B1
Conditional Go
Ghana
2
Malaria
GHN-202-G03-M
A
Go
Guinea
2
HIV/AIDS
GIN-202-G01-H
B2
Conditional Go
Haiti
1
HIV/AIDS
HTI-102-G01-H
A
Go
Haiti
1
HIV/AIDS
HTI-102-G02-H
B1
Go
Honduras
1
HIV/AIDS
HND-102-G01-H
B2
Conditional Go
Honduras
1
TB
HND-102-G02-T
B2
Conditional Go
Honduras
1
Malaria
HND-102-G03-M
B2
Conditional Go
India
2
TB
IDA-202-G03-T
B1
Conditional Go
India
2
HIV/AIDS
IDA-202-G02-H
B1
Conditional Go
India
1
TB
IDA-102-G01-T
A
Go
Indonesia
1
TB
IND-102-G01-T
B1
Go
Indonesia
1
Malaria
IND-102-G02-M
B1
Conditional Go
Indonesia
1
HIV/AIDS
IND-102-G03-H
B2
Conditional Go
Jamaica
3
HIV/AIDS
JAM-304-G01-H
A
Conditional Go
Jordan
2
HIV/AIDS
JOR-202-G01-H
A
Go
Kazakhstan
2
HIV/AIDS
KAZ-202-G01-H
B1
Go
Kenya
2
TB
KEN-202-G04-T
B2
Conditional Go
Kenya
2
Malaria
KEN-202-G05-M
B2
Conditional Go
Kyrgyzstan
2
TB
KGZ-202-G02-T
B1
Go
Kyrgyzstan
2
HIV/AIDS
KGZ-202-G01-H
B1
Go
Lao PDR
2
TB
LAO-202-G03-T
A
Go
Lao PDR
1
HIV/AIDS
LAO-102-G01-H
B2
Conditional Go
Lao PDR
1
Malaria
LAO-102-G02-M
B2
Conditional Go
Lesotho
2
TB
LSO-202-G02-T
B2
Conditional Go
Lesotho
2
HIV/AIDS
LSO-202-G01-H
B2
Conditional Go
Lutheran World Feder'n
1
HIV/AIDS
WRL-102-G01-H
B1
Go
Madagascar
1
Malaria
MDG-102-G01-M
B1
Go
Madagascar
2
HIV/AIDS
MDG-202-G02-H
A
Go
Madagascar
2
HIV/AIDS
MDG-202-G03-H
B1
Go
Malawi
1
HIV/AIDS
MLW-102-G01-H
B1
Conditional Go
Mauritania
2
Malaria
MRT-202-G02-M
B1
Go
Mauritania
2
TB
MRT-202-G01-T
B1
Go
Moldova
1
HIV and TB
MOL-102-G01-C
A
Go
Mali
1
Malaria
MAL-102-G01-M
B2
Conditional Go
Mongolia
1
TB
MON-102-G01-T
A
Go
Mongolia
2
HIV/AIDS
MON-202-G02-H
A
Go
Morocco
1
HIV/AIDS
MOR-102-G01-H
A
Go
Multi-Country Africa
2
Malaria
MAF-202-G01-M
A
Go
Multi-Country W. Pacific
2
HIV/AIDS
MWP-202-G01-H
B2
Conditional Go
Multi-Country W. Pacific
2
Malaria
MWP-202-G02-M
B1
Go
Multi-Country W. Pacific
2
TB
MWP-202-G03-T
B1
Go
Nicaragua
2
Malaria
NIC-202-G01-M
B1
Go
Nicaragua
2
TB
NIC-202-G02-T
B1
Go
Nicaragua
2
HIV/AIDS
NIC-202-G03-H
B1
Go
Peru
2
HIV/AIDS
PER-202-G01-H
B1
Conditional Go
Peru
2
TB
PER-202-G02-T
B1
Conditional Go
Pakistan
2
HIV/AIDS
PKS-202-G01-H
B2
Conditional Go
Pakistan
2
TB
PKS-202-G03-T
B2
Conditional Go
Panama
1
TB
PAN-102-G01-T
A
Go
Philippines
2
Malaria
PHL-202-G01-M
B1
Go
Philippines
2
TB
PHL-202-G02-T
A
Go
Romania
2
TB
ROM-202-G02-T
B1
Conditional Go
Romania
2
HIV/AIDS
ROM-202-G01-H
B1
Go
Rwanda
1
HIV and TB
RWN-102-G01-C
A
Go
Senegal
1
HIV/AIDS
SNG-102-G01-H
C
Conditional Go
Senegal
1
Malaria
SNG-102-G02-M
C
No Go
Serbia
1
HIV/AIDS
SER-102-G01-H
B1
Conditional Go
Sierra Leone
2
TB
SLE-202-G01-T
B1
Conditional Go
Somalia
2
Malaria
SOM-202-G01-M
B1
Go
South Africa
1
HIV and TB
SAF-102-G02-C
B2
No Go
Sri Lanka
1
TB
SRL-102-G03-T
B1
Conditional Go
Sri Lanka
1
Malaria
SRL-102-G01-M
B1
Conditional Go
Sri Lanka
1
Malaria
SRL-102-G02-M
B1
Conditional Go
Swaziland
2
Malaria
SWZ-202-G02-M
B2
Conditional Go
Swaziland
2
HIV/AIDS
SWZ-202-G01-H
B1
Conditional Go
Tajikistan
1
HIV/AIDS
TAJ-102-G01-H
A
Go
Tanzania
1
Malaria
TNZ-102-G01-M
B2
Conditional Go
Tanzania/Zanzibar
2
HIV/AIDS
ZAN-202-G02-H
B1
Go
Thailand
1
HIV/AIDS
THA-102-G01-H
B1
Conditional Go
Thailand
2
HIV/AIDS
THA-202-G03-H
B1
Go
Thailand
2
Malaria
THA-202-G05-M
B1
Conditional Go
Thailand
1
TB
THA-102-G02-T
B2
Conditional Go
Timor Leste (East Timor)
2
Malaria
TMP-202-G01-M
B1
Conditional Go
Togo
2
HIV/AIDS
TGO-202-G01-H
B2
Conditional Go
Ukraine
1
HIV/AIDS
UKR-102-G04-H
B1
Conditional Go
Uganda
1
HIV/AIDS
UGD-102-G01-H
B2
Conditional Go
Vietnam
1
TB
VTN-102-G02-T
B1
Go
Vietnam
1
HIV/AIDS
VTN-102-G01-H
B1
Go
Yemen
2
Malaria
YEM-202-G01-M
B2
Conditional Go
Zambia
1
HIV/AIDS
ZAM-102-G01-H
B1
Go
Zambia
1
Malaria
ZAM-102-G02-M
B1
Go
Zambia
1
TB
ZAM-102-G03-T
B1
Go
Zambia
1
HIV/AIDS
ZAM-102-G04-H
A
Go
Zambia
1
Malaria
ZAM-102-G05-M
B1
Go
Zambia
1
TB
ZAM-102-G06-T
A
Go
Zambia
1
HIV/AIDS
ZAM-102-G08-H
B1
Go
Zanzibar
1
Malaria
ZAN-102-G01-M
B1
Go
| Rating | Number of grants | Percent |
| A | 28 | 23% |
| B1 | 69 | 56% |
| B2 | 25 | 20% |
| C | 2 | 2% |
| Total | 124 | 100% |
| Board decision | Number of grants | Percent |
| Go | 63 | 51% |
| Conditional Go | 59 | 48% |
| Revised Go | 0 | 0% |
| No Go | 2 | 2% |
| Total | 124 | 100% |
The 124 grants for which Phase 2 decisions have been made
| Country | Round | Disease Component | Grant number | Grant Rating | Board decision re Phase 2 |
| Argentina | 1 | HIV/AIDS | ARG-102-G01-H | A | Conditional Go |
| Armenia | 2 | HIV/AIDS | ARM-202-G01-H | A | Go |
| Bangladesh | 2 | HIV/AIDS | BAN-202-G01-H | A | Go |
| Benin | 1 | Malaria | BEN-102-G01-M | B1 | Conditional Go |
| Benin | 2 | TB | BEN-202-G02-T | B1 | Go |
| Benin | 2 | HIV/AIDS | BEN-202-G03-H | B1 | Go |
| Bulgaria | 2 | HIV/AIDS | BUL-202-G01-H | A | Go |
| Burkina Faso | 2 | HIV/AIDS | BUR-202-G02-H | A | Go |
| Burundi | 2 | Malaria | BRN-202-G02-M | B1 | Conditional Go |
| Burundi | 1 | HIV/AIDS | BRN-102-G01-H | B1 | Go |
| Chad | 2 | TB | TCD-202-G01-T | B1 | Conditional Go |
| Chile | 1 | HIV/AIDS | CHL-102-G01-H | B1 | Go |
| Cambodia | 1 | HIV/AIDS | CAM-102-G01-H | B1 | Conditional Go |
| Cambodia | 2 | HIV/AIDS | CAM-202-G02-H | B1 | Conditional Go |
| Cambodia | 2 | Malaria | CAM-202-G03-M | B1 | Go |
| Cambodia | 2 | TB | CAM-202-G04-T | B1 | Conditional Go |
| Central African Republic | 2 | HIV/AIDS | CAF-202-G01-H | B1 | Go |
| China | 1 | TB | CHN-102-G01-T | A | Go |
| China | 1 | Malaria | CHN-102-G02-M | A | Go |
| Columbia | 2 | HIV/AIDS | COL-202-G01-H | B1 | Conditional Go |
| Costa Rica | 2 | HIV/AIDS | COR-202-G01-H | B2 | Conditional Go |
| Cote d'Ivoire | 3 | TB | CIV-304-G03-T | A | Go |
| Cote d'Ivoire | 2 | HIV/AIDS | CIV-202-G01-H | B1 | Conditional Go |
| Croatia | 2 | HIV/AIDS | HRV-202-G01-H | B1 | Go |
| Cuba | 1 | HIV/AIDS | CUB-202-G01-H | A | Conditional Go |
| Democratic Rep. of Congo | 2 | TB | ZAR-202-G01-T | B1 | Conditional Go |
| El Salvador | 2 | HIV/AIDS | SLV-202-G01-H | B1 | Conditional Go |
| El Salvador | 2 | TB | SLV-202-G02-T | A | Go |
| Estonia | 2 | HIV/AIDS | EST-202-G01-H | B1 | Go |
| Eritrea | 2 | Malaria | ERT-202-G01-M | B1 | Conditional Go |
| Ethiopia | 2 | HIV/AIDS | ETH-202-G03-H | B1 | Conditional Go |
| Ethiopia | 2 | Malaria | ETH-202-G02-M | B2 | Conditional Go |
| Ethiopia | 1 | TB | ETH-102-G01-T | B2 | Conditional Go |
| Georgia | 3 | Malaria | GEO-304-G02-M | B1 | Go |
| Georgia | 2 | HIV/AIDS | GEO-202-G01-H | B1 | Go |
| Ghana | 1 | HIV/AIDS | GHN-102-G01-H | B1 | Conditional Go |
| Ghana | 1 | TB | GHN-102-G02-T | B1 | Conditional Go |
| Ghana | 2 | Malaria | GHN-202-G03-M | A | Go |
| Guinea | 2 | HIV/AIDS | GIN-202-G01-H | B2 | Conditional Go |
| Haiti | 1 | HIV/AIDS | HTI-102-G01-H | A | Go |
| Haiti | 1 | HIV/AIDS | HTI-102-G02-H | B1 | Go |
| Honduras | 1 | HIV/AIDS | HND-102-G01-H | B2 | Conditional Go |
| Honduras | 1 | TB | HND-102-G02-T | B2 | Conditional Go |
| Honduras | 1 | Malaria | HND-102-G03-M | B2 | Conditional Go |
| India | 2 | TB | IDA-202-G03-T | B1 | Conditional Go |
| India | 2 | HIV/AIDS | IDA-202-G02-H | B1 | Conditional Go |
| India | 1 | TB | IDA-102-G01-T | A | Go |
| Indonesia | 1 | TB | IND-102-G01-T | B1 | Go |
| Indonesia | 1 | Malaria | IND-102-G02-M | B1 | Conditional Go |
| Indonesia | 1 | HIV/AIDS | IND-102-G03-H | B2 | Conditional Go |
| Jamaica | 3 | HIV/AIDS | JAM-304-G01-H | A | Conditional Go |
| Jordan | 2 | HIV/AIDS | JOR-202-G01-H | A | Go |
| Kazakhstan | 2 | HIV/AIDS | KAZ-202-G01-H | B1 | Go |
| Kenya | 2 | TB | KEN-202-G04-T | B2 | Conditional Go |
| Kenya | 2 | Malaria | KEN-202-G05-M | B2 | Conditional Go |
| Kyrgyzstan | 2 | TB | KGZ-202-G02-T | B1 | Go |
| Kyrgyzstan | 2 | HIV/AIDS | KGZ-202-G01-H | B1 | Go |
| Lao PDR | 2 | TB | LAO-202-G03-T | A | Go |
| Lao PDR | 1 | HIV/AIDS | LAO-102-G01-H | B2 | Conditional Go |
| Lao PDR | 1 | Malaria | LAO-102-G02-M | B2 | Conditional Go |
| Lesotho | 2 | TB | LSO-202-G02-T | B2 | Conditional Go |
| Lesotho | 2 | HIV/AIDS | LSO-202-G01-H | B2 | Conditional Go |
| Lutheran World Feder'n | 1 | HIV/AIDS | WRL-102-G01-H | B1 | Go |
| Madagascar | 1 | Malaria | MDG-102-G01-M | B1 | Go |
| Madagascar | 2 | HIV/AIDS | MDG-202-G02-H | A | Go |
| Madagascar | 2 | HIV/AIDS | MDG-202-G03-H | B1 | Go |
| Malawi | 1 | HIV/AIDS | MLW-102-G01-H | B1 | Conditional Go |
| Mauritania | 2 | Malaria | MRT-202-G02-M | B1 | Go |
| Mauritania | 2 | TB | MRT-202-G01-T | B1 | Go |
| Moldova | 1 | HIV and TB | MOL-102-G01-C | A | Go |
| Mali | 1 | Malaria | MAL-102-G01-M | B2 | Conditional Go |
| Mongolia | 1 | TB | MON-102-G01-T | A | Go |
| Mongolia | 2 | HIV/AIDS | MON-202-G02-H | A | Go |
| Morocco | 1 | HIV/AIDS | MOR-102-G01-H | A | Go |
| Multi-Country Africa | 2 | Malaria | MAF-202-G01-M | A | Go |
| Multi-Country W. Pacific | 2 | HIV/AIDS | MWP-202-G01-H | B2 | Conditional Go |
| Multi-Country W. Pacific | 2 | Malaria | MWP-202-G02-M | B1 | Go |
| Multi-Country W. Pacific | 2 | TB | MWP-202-G03-T | B1 | Go |
| Nicaragua | 2 | Malaria | NIC-202-G01-M | B1 | Go |
| Nicaragua | 2 | TB | NIC-202-G02-T | B1 | Go |
| Nicaragua | 2 | HIV/AIDS | NIC-202-G03-H | B1 | Go |
| Peru | 2 | HIV/AIDS | PER-202-G01-H | B1 | Conditional Go |
| Peru | 2 | TB | PER-202-G02-T | B1 | Conditional Go |
| Pakistan | 2 | HIV/AIDS | PKS-202-G01-H | B2 | Conditional Go |
| Pakistan | 2 | TB | PKS-202-G03-T | B2 | Conditional Go |
| Panama | 1 | TB | PAN-102-G01-T | A | Go |
| Philippines | 2 | Malaria | PHL-202-G01-M | B1 | Go |
| Philippines | 2 | TB | PHL-202-G02-T | A | Go |
| Romania | 2 | TB | ROM-202-G02-T | B1 | Conditional Go |
| Romania | 2 | HIV/AIDS | ROM-202-G01-H | B1 | Go |
| Rwanda | 1 | HIV and TB | RWN-102-G01-C | A | Go |
| Senegal | 1 | HIV/AIDS | SNG-102-G01-H | C | Conditional Go |
| Senegal | 1 | Malaria | SNG-102-G02-M | C | No Go |
| Serbia | 1 | HIV/AIDS | SER-102-G01-H | B1 | Conditional Go |
| Sierra Leone | 2 | TB | SLE-202-G01-T | B1 | Conditional Go |
| Somalia | 2 | Malaria | SOM-202-G01-M | B1 | Go |
| South Africa | 1 | HIV and TB | SAF-102-G02-C | B2 | No Go |
| Sri Lanka | 1 | TB | SRL-102-G03-T | B1 | Conditional Go |
| Sri Lanka | 1 | Malaria | SRL-102-G01-M | B1 | Conditional Go |
| Sri Lanka | 1 | Malaria | SRL-102-G02-M | B1 | Conditional Go |
| Swaziland | 2 | Malaria | SWZ-202-G02-M | B2 | Conditional Go |
| Swaziland | 2 | HIV/AIDS | SWZ-202-G01-H | B1 | Conditional Go |
| Tajikistan | 1 | HIV/AIDS | TAJ-102-G01-H | A | Go |
| Tanzania | 1 | Malaria | TNZ-102-G01-M | B2 | Conditional Go |
| Tanzania/Zanzibar | 2 | HIV/AIDS | ZAN-202-G02-H | B1 | Go |
| Thailand | 1 | HIV/AIDS | THA-102-G01-H | B1 | Conditional Go |
| Thailand | 2 | HIV/AIDS | THA-202-G03-H | B1 | Go |
| Thailand | 2 | Malaria | THA-202-G05-M | B1 | Conditional Go |
| Thailand | 1 | TB | THA-102-G02-T | B2 | Conditional Go |
| Timor Leste (East Timor) | 2 | Malaria | TMP-202-G01-M | B1 | Conditional Go |
| Togo | 2 | HIV/AIDS | TGO-202-G01-H | B2 | Conditional Go |
| Ukraine | 1 | HIV/AIDS | UKR-102-G04-H | B1 | Conditional Go |
| Uganda | 1 | HIV/AIDS | UGD-102-G01-H | B2 | Conditional Go |
| Vietnam | 1 | TB | VTN-102-G02-T | B1 | Go |
| Vietnam | 1 | HIV/AIDS | VTN-102-G01-H | B1 | Go |
| Yemen | 2 | Malaria | YEM-202-G01-M | B2 | Conditional Go |
| Zambia | 1 | HIV/AIDS | ZAM-102-G01-H | B1 | Go |
| Zambia | 1 | Malaria | ZAM-102-G02-M | B1 | Go |
| Zambia | 1 | TB | ZAM-102-G03-T | B1 | Go |
| Zambia | 1 | HIV/AIDS | ZAM-102-G04-H | A | Go |
| Zambia | 1 | Malaria | ZAM-102-G05-M | B1 | Go |
| Zambia | 1 | TB | ZAM-102-G06-T | A | Go |
| Zambia | 1 | HIV/AIDS | ZAM-102-G08-H | B1 | Go |
| Zanzibar | 1 | Malaria | ZAN-102-G01-M | B1 | Go |
Publication Date:
2006-04-17
